Epilepsy Market Segmentation:
Diagnosis & Treatment Segment Analysis
The imaging devices segment is attributed to holding the largest share of the market during the forecast period. The major factor attributed to segment growth is the increasing diagnostic imaging services across the globe and high investments made in the medical devices sector. As of 2022, the total worth of diagnostic imaging devices was estimated to be approximately USD 45 billion globally. Furthermore, the increasing advantages of imaging devices to detect and diagnose epilepsy are also estimated to bring lucrative growth opportunities for segment growth.
End-user Segment Analysis
The hospitals segment in epilepsy market is projected to hold a significant share during the analysis period with a notable revenue generation. Effective treatment of neurological disorders and other chronic diseases is often conducted in hospitals with the availability of specialized doctors and advanced medical equipment. In addition, it’s easier and more convenient for the diagnosis and treatment processes of epilepsy and the increased inflow and outflow of patients in the hospitals for the expansion of the segment size.
Our in-depth analysis of the global market includes the following segments:
|
By Diagnosis & Treatment |
|
|
By Condition |
|
|
By Treatment |
|
|
By End-User |
|
